NCT02972333 Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M Status UNKNOWN Phase PHASE3
NCT02971293 Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871 Status COMPLETED Phase PHASE2
NCT02970422 Chronic Obstructive Pulmonary Disease Patient Preferences Survey Status COMPLETED Phase N/A
NCT02969798 Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) Status RECRUITING Phase NA
NCT02968914 Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02967159 A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT02963688 BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer Status COMPLETED Phase N/A
NCT02963116 A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet Status COMPLETED Phase PHASE1
NCT02962960 A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations Status COMPLETED Phase PHASE2
NCT02962492 An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes Status COMPLETED Phase NA
NCT02962063 Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02956811 Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? Status COMPLETED Phase PHASE4
NCT02955316 Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China Status COMPLETED Phase N/A
NCT02954523 Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations Status TERMINATED Phase PHASE1/PHASE2
NCT02953457 Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation Status COMPLETED Phase PHASE2
NCT02950805 A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT02946632 Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes Status UNKNOWN Phase PHASE3
NCT02946580 Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients Status TERMINATED Phase PHASE4
NCT02938793 Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors Status TERMINATED Phase PHASE2